©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessLeukemia, acute myeloic; hereditary; differential diagnosis

Summary

Short information

A curated panel containing 15 guideline-curated genes and altogether 22 curated genes for the comprehensive analysis of the genetic susceptibility for acute myeloic leukemia

ID
LP0230
Number of genes
19 Accredited laboratory test
Examined sequence length
44,6 kb (Core-/Core-canditate-Genes)
58,2 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

[Sanger]

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
ANKRD265133NM_014915.3AD
BRCA15592NM_007294.4AR
BRCA210257NM_000059.4AR
CEBPA1077NM_004364.5AD
DDX411935NM_016222.4AD
ETV61359NM_001987.5Gen Fusion
GATA21443NM_032638.5AD
MLH12271NM_000249.4AR
MSH22805NM_000251.3AR
MSH64083NM_000179.3AR
PMS22589NM_000535.7AR
RUNX11443NM_001754.5AD, Gen Fusion
TERT3399NM_198253.3AD, AR
TP531182NM_000546.6AD
ACD1647NM_001082486.2AD, AR
CHEK21632NM_007194.4AD
RTEL13732NM_032957.5AR, AD
SAMD94770NM_001193307.2AD
SRP721833NM_001267722.2AD

Informations about the disease

Clinical Comment

Neoplasms arising from precursor cells of the myeloid differentiation; characterized by clonal expansion of myeloid blasts, with fever, pallor, anemia, hemorrhages + recurrent infections

 

Synonyms
  • Alias: AML
  • Allelic: Adrenocortical carcinoma, pediatric (TP53)
  • Allelic: Ataxia-pancytopenia syndrome (SAMD9L)
  • Allelic: Basal cell carcinoma 7 (TP53)
  • Allelic: Bone marrow failure syndrome 1 (SRP72)
  • Allelic: Breast cancer, male, susceptibility to (BRCA2)
  • Allelic: Breast cancer, somatic (TP53)
  • Allelic: Breast cancer, susceptibility to (CHEK2)
  • Allelic: Breast-ovarian cancer, familial, 1 (BRCA1)
  • Allelic: Breast-ovarian cancer, familial, 2 (BRCA2)
  • Allelic: Choroid plexus papilloma (TP53)
  • Allelic: Colorectal cancer (TP53)
  • Allelic: Colorectal cancer, hereditary nonpolyposis, type 1 (MSH2)
  • Allelic: Colorectal cancer, hereditary nonpolyposis, type 2 (MLH1)
  • Allelic: Colorectal cancer, hereditary nonpolyposis, type 4 (PMS2)
  • Allelic: Colorectal cancer, hereditary nonpolyposis, type 5 (MSH6)
  • Allelic: Colorectal cancer, susceptibility to (CHEK2)
  • Allelic: Dyskeratosis congenita, AD 2 (TERT)
  • Allelic: Dyskeratosis congenita, AD 4 (RTEL1)
  • Allelic: Dyskeratosis congenita, AD 6 (ACD)
  • Allelic: Dyskeratosis congenita, AR 4 (TERT)
  • Allelic: Dyskeratosis congenita, AR 5 (RTEL1)
  • Allelic: Dyskeratosis congenita, AR 7 (ACD)
  • Allelic: Emberger syndrome (GATA2)
  • Allelic: Endometrial cancer, familial (MSH6)
  • Allelic: Glioblastoma 3 (BRCA2)
  • Allelic: Glioma susceptibility 1 (TP53)
  • Allelic: Hepatocellular carcinoma, somatic (TP53)
  • Allelic: Immunodeficiency 21 (GATA2)
  • Allelic: Li-Fraumeni syndrome (TP53)
  • Allelic: Li-Fraumeni syndrome 2 (CHEK2)
  • Allelic: MIRAGE syndrome (SAMD9)
  • Allelic: Medulloblastoma (BRCA2)
  • Allelic: Melanoma, cutaneous malignant, 9 (TERT)
  • Allelic: Muir-Torre syndrome (MLH1, MSH2, )
  • Allelic: Myelodysplastic syndrome, somatic (TET2)
  • Allelic: Myelodysplastic syndrome, susceptibility to (GATA2)
  • Allelic: Nasopharyngeal carcinoma, somatic (TP53)
  • Allelic: Osteosarcoma (TP53)
  • Allelic: Osteosarcoma, somatic (CHEK2)
  • Allelic: Pancreatic cancer 2 (BRCA2)
  • Allelic: Pancreatic cancer, somatic (TP53)
  • Allelic: Pancreatic cancer, susceptibility to, 4 (BRCA1)
  • Allelic: Platelet disorder, familial, with associated myeloid malignancy (RUNX1)
  • Allelic: Prostate cancer (BRCA2)
  • Allelic: Prostate cancer, familial, susceptibility to
  • Allelic: Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1 (TERT)
  • Allelic: Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3 (RTEL1)
  • Allelic: Thrombocytopenia 5 (ETV6)
  • Allelic: Tumoral calcinosis, familial, normophosphatemic (SAMD9)
  • Allelic: Wilms tumor (BRCA2)
  • Bone marrow failure syndrome 5 (TP53)
  • Fanconi anemia, complementation group D1 (BRCA2)
  • Fanconi anemia, complementation group S (BRCA1)
  • Immunodeficiency 75 (TET2)
  • Leukemia, acute myeloid (CEBPA)
  • Leukemia, acute myeloid (RUNX2)
  • Leukemia, acute myeloid (TERT)
  • Leukemia, acute myeloid, somatic (CEBPA)
  • Leukemia, acute myeloid, somatic (ETV6)
  • Leukemia, acute myeloid, susceptibility to (GATA2)
  • Mismatch repair cancer syndrome 1 (MLH1)
  • Mismatch repair cancer syndrome 2 (MSH2)
  • Mismatch repair cancer syndrome 3 (MSH6)
  • Mismatch repair cancer syndrome 4 (PMS2)
  • Monosomy 7 myelodysplasia + leukemia syndrome 2 (SAMD9)
  • Monosomy 7 myelodysplasia and leukemia syndrome 1 (SAMD9L)
  • Myeloproliferative/lymphoprolif. neoplasms, familial (multiple types), susceptibility to (DDX41)
  • Neutropenia, severe congenital, 8, AD (SRP54)
Heredity, heredity patterns etc.
  • AD
  • AR
  • Gen Fusion
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

No text defined